Detalhe da pesquisa
1.
A Smartphone App for Real-Time Assessment of Malaria Prophylaxis Adverse Events.
Telemed J E Health
; 30(5): 1436-1442, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38215269
2.
Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection.
Clin Microbiol Rev
; 35(2): e0015221, 2022 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35239422
3.
A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease.
Clin Infect Dis
; 76(3): e1186-e1194, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35925555
4.
Feminist contributions on sexual experiences of women with serious mental illness: a literature review.
Arch Womens Ment Health
; 25(5): 853-870, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35994099
5.
A Branched and Double Alpha-Gal-Bearing Synthetic Neoglycoprotein as a Biomarker for Chagas Disease.
Molecules
; 27(17)2022 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36080480
6.
Anti-Trypanosoma cruzi Activity of Metabolism Modifier Compounds.
Int J Mol Sci
; 22(2)2021 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33445756
7.
Plasma-Derived Extracellular Vesicles as Potential Biomarkers in Heart Transplant Patient with Chronic Chagas Disease.
Emerg Infect Dis
; 26(8): 1846-1851, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32687028
8.
Towards a New Strategy for Diagnosis of Congenital Trypanosoma cruzi Infection.
J Clin Microbiol
; 55(5): 1396-1407, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28202792
9.
Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives.
Mem Inst Oswaldo Cruz
; 110(3): 422-32, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25946151
10.
Efficacy and safety of fexinidazole for treatment of chronic indeterminate Chagas disease (FEXI-12): a multicentre, randomised, double-blind, phase 2 trial.
Lancet Infect Dis
; 24(4): 395-403, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38218194
11.
Evaluation of the accuracy of a multi-infection screening test based on a multiplex immunoassay targeting imported diseases common in migrant populations.
Travel Med Infect Dis
; 57: 102681, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38141899
12.
Benznidazole-related adverse drug reactions and their relationship to serum drug concentrations in patients with chronic chagas disease.
Antimicrob Agents Chemother
; 57(1): 390-5, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23114763
13.
Development of vaccines for Chagas disease (CRUZIVAX): stakeholders' preferences and potential impacts on healthcare.
Gac Sanit
; 37: 102275, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36563537
14.
State-of-the-Art in the Drug Discovery Pathway for Chagas Disease: A Framework for Drug Development and Target Validation.
Res Rep Trop Med
; 14: 1-19, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37337597
15.
Analysis of the costs incurred by patients with Chagas disease: The experience in endemic municipalities in Colombia.
Acta Trop
; 245: 106963, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37302690
16.
Development and Application of an Assay to Evaluate the Anti-Parasitic Effect of Humoral Responses against Trypanosoma cruzi.
Microorganisms
; 11(2)2023 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36838206
17.
Five-year serological and clinical evolution of chronic Chagas disease patients in Cochabamba, Bolivia.
PLoS Negl Trop Dis
; 17(12): e0011498, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38157376
18.
Characterization of Latin American migrants at risk for Trypanosoma cruzi infection in a non-endemic setting. Insights into initial evaluation of cardiac and digestive involvement.
PLoS Negl Trop Dis
; 17(7): e0011330, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37440480
19.
Correction: Clinical profile and mortality in patients with T. cruzi/HIV co-infection from the multicenter data base of the "Network for healthcare and study of Trypanosoma cruzi/HIV co-infection and other immunosuppression conditions".
PLoS Negl Trop Dis
; 17(1): e0011036, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36598894
20.
Extracellular Vesicles in Trypanosoma cruzi Infection: Immunomodulatory Effects and Future Perspectives as Potential Control Tools against Chagas Disease.
J Immunol Res
; 2022: 5230603, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36033396